Your browser doesn't support javascript.
loading
Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: A multi-institutional cohort study.
Zhang, Shijia; Tang, Kimberly; Wan, Guihong; Nguyen, Nga; Lu, Chenyue; Ugwu-Dike, Pearl; Raval, Neel; Seo, Jayhyun; Alexander, Nora A; Jairath, Ruple; Phillipps, Jordan; Leung, Bonnie W; Roster, Kathleen; Chen, Wenxin; Zubiri, Leyre; Boland, Genevieve; Chen, Steven T; Tsao, Hensin; Demehri, Shadmehr; LeBoeuf, Nicole R; Reynolds, Kerry L; Yu, Kun-Hsing; Gusev, Alexander; Kwatra, Shawn G; Semenov, Yevgeniy R.
Afiliação
  • Zhang S; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts.
  • Tang K; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Wan G; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts.
  • Nguyen N; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Lu C; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts.
  • Ugwu-Dike P; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Raval N; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Seo J; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Alexander NA; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Jairath R; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Phillipps J; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Leung BW; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Roster K; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Chen W; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts.
  • Zubiri L; Division of Oncology and Hematology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Boland G; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts.
  • Chen ST; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Tsao H; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Demehri S; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Center for Cancer Immunology and Cutaneous Biology Research Center, Center for Cancer Research, Massachusetts General Hospital Cancer Center, Massachusetts General Hos
  • LeBoeuf NR; Department of Dermatology, Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Reynolds KL; Division of Oncology and Hematology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Yu KH; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts.
  • Gusev A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Kwatra SG; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Semenov YR; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: ysemenov@mgh.harvard.edu.
J Am Acad Dermatol ; 88(5): 1024-1032, 2023 05.
Article em En | MEDLINE | ID: mdl-36736626
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Exantema / Melanoma Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Exantema / Melanoma Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2023 Tipo de documento: Article